Madrigal Pharmaceuticals
#2631
Rank
$5.3B
Marketcap
United States
Country
Dr. Paul A. Friedman M.D. (Chairman & CEO)
Dr. Rebecca A. Taub M.D. (Founder, Chief Medical Officer, Pres of R&D and Director)
Mr. Alex G. Howarth (Sr. VP & CFO)
Summary
History
Madrigal Pharmaceuticals was founded in 1992, and since then the company has been developing drug candidates that target metabolic and cardiovascular diseases, as well as other conditions. The company has developed a pipeline of potential treatments for its targeted conditions consisting of small molecules, monoclonal antibodies, and other biologics.
Mission
Vision
Key Team
Mr. Brian J. Lynch J.D. (Sr. VP & Gen. Counsel)
Mr. Remy Sukhija (Sr. VP & Chief Commercial Officer)
Dr. Kianoush Motesharei Ph.d. (Sr. VP of Bus. & Corp. Devel.)
Mr. Thomas W. Hare (Sr. VP of Clinical Management)
Mr. Edward Chiang (Sr. VP of Clinical & Technical Operations)
Dr. Robert E. Waltermire Ph.D. (Chief Pharmaceutical Devel. Officer)
Dr. Stephen Dodge M.B.A., Pharm.D. (Sr. VP of Global Medical Affairs)
Recognition and Awards
References
Dr. Paul A. Friedman M.D. (Chairman & CEO)
Dr. Rebecca A. Taub M.D. (Founder, Chief Medical Officer, Pres of R&D and Director)
Mr. Alex G. Howarth (Sr. VP & CFO)